Q32 Bio (QTTB) FCF Margin Growth (3y) (2021 - 2023)
Q32 Bio (QTTB) FCF Margin Growth (3y) (2021 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Q32 Bio |
167.59 Mn |
116.84 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
170,052.00 |
| Sep 30, 2023 |
598,803.00 |
| Jun 30, 2023 |
496,618.00 |
| Mar 31, 2023 |
404,026.00 |
| Dec 31, 2022 |
124,443.00 |
| Sep 30, 2022 |
-89,156.00 |
| Jun 30, 2022 |
436,537.00 |
| Mar 31, 2022 |
473,893.00 |
| Dec 31, 2021 |
-181,263.00 |
| Sep 30, 2021 |
-35,439.00 |
| Jun 30, 2021 |
-7,271.00 |
| Mar 31, 2021 |
87,605.00 |
